Jill Dejong

Assistant Professor
Research Summary
Dr. de Jong treats children with all types of cancer and blood diseases. She has specialized expertise in bone marrow failure, leukemia, autoimmune blood diseases (such as autoimmune hemolytic anemia, autoimmune neutropenia, immune thrombocytopenia purpura and Evans syndrome), hemoglobinopathies (such as thalassemia and sickle cell disease), and bleeding and clotting disorders. Her research focuses on hematopoietic stem cells and genetic risks for hematologic malignancy. She is co-director of the Pediatric Cancer Genetic Risk clinic and the director of the Pediatric Bone Marrow Failure clinic. Dr. de Jong has also invested her time in education, serving as the Director of Pediatric Fellowship Training for the Department of Pediatrics, as well as the Program Director for the Pediatric Hematology-Oncology Fellowship.
Keywords
Bone Marrow Failure syndromes, Cancer Genetic Risk, Hematopoietic Malignancy, Pediatric Hematology, Anemias, Neutropenias, Thrombocytopenias, Aplastic Anemias, ITP, Hemoglobinopathies, Bleeding disorders, Clotting disorders
Education
  • Dana Farber Cancer Institute and Boston Children's Hospital, Boston, MA, Fellowship Pediatric Hematology-Oncology 06/2005
  • Boston Children's Hospital, Boston, MA, Residency Pediatrics 06/2002
  • University of Wisconsin, Madison, WI, MD Medicine 05/1999
  • University of Wisconsin, Madison, WI, PhD Cancer Biology 05/1997
  • University of Chicago, Chicago, IL, AB Biology 06/1990
Awards & Honors
  • 1990 - Phi Beta Kappa University of Chicago
  • 1998 - Alpha Omega Alpha, Medical Honor Society University of Wisconsin
  • 2010 - Pritzker Scholar Award University of Chicago
  • 2013 - now Regional Top Doctor, Pediatric Hematology-Oncology Castle Connolly
Publications
  1. Baeten JT, Waarts MR, Pruitt MM, Chan WC, Andrade J, de Jong JLO. The side population enriches for leukemia-propagating cell activity and Wnt pathway expression in zebrafish acute lymphoblastic leukemia. Haematologica. 2019 Jul; 104(7):1388-1395. View in: PubMed

  2. Baeten JT, de Jong JLO. Genetic Models of Leukemia in Zebrafish. Front Cell Dev Biol. 2018; 6:115. View in: PubMed

  3. Esteban YM, de Jong JLO, Tesher MS. An Overview of Hemophagocytic Lymphohistiocytosis. Pediatr Ann. 2017 Aug 01; 46(8):e309-e313. View in: PubMed

  4. Pruitt MM, Marin W, Waarts MR, de Jong JLO. Isolation of the Side Population in Myc-induced T-cell Acute Lymphoblastic Leukemia in Zebrafish. J Vis Exp. 2017 05 04; (123). View in: PubMed

  5. Villanueva G, de Jong JL, McNeer JL. Intravenous Immunoglobulin in the Treatment of Hematologic Disorders in Pediatrics. Pediatr Ann. 2017 Jan 01; 46(1):e13-e18. View in: PubMed

  6. McConnell SC, Hernandez KM, Wcisel DJ, Kettleborough RN, Stemple DL, Yoder JA, Andrade J, de Jong JL. Alternative haplotypes of antigen processing genes in zebrafish diverged early in vertebrate evolution. Proc Natl Acad Sci U S A. 2016 08 23; 113(34):E5014-23. View in: PubMed

  7. Nassin ML, Lapping-Carr G, de Jong JL. Anemia in the Neonate: The Differential Diagnosis and Treatment. Pediatr Ann. 2015 Jul; 44(7):e159-63. View in: PubMed

  8. Ansari DO, Lapping-Carr G, Alikhan M, Tsoukas ML, Stein SL, de Jong JL. A neonate with a vesiculopustular rash. Pediatr Ann. 2015 Jan; 44(1):e1-5. View in: PubMed

  9. Dirscherl H, McConnell SC, Yoder JA, de Jong JL. The MHC class I genes of zebrafish. Dev Comp Immunol. 2014 Sep; 46(1):11-23. View in: PubMed

  10. McConnell SC, Restaino AC, de Jong JL. Multiple divergent haplotypes express completely distinct sets of class I MHC genes in zebrafish. Immunogenetics. 2014 Mar; 66(3):199-213. View in: PubMed